142 related articles for article (PubMed ID: 32952448)
1. Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development.
Temmel E; Eicke MJ; Cascella F; Seidel-Morgenstern A; Lorenz H
Cryst Growth Des; 2019 Jun; 19(6):3148-3157. PubMed ID: 32952448
[TBL] [Abstract][Full Text] [Related]
2. A Comparative Study of Coupled Preferential Crystallizers for the Efficient Resolution of Conglomerate-Forming Enantiomers.
Majumder A; Nagy ZK
Pharmaceutics; 2017 Dec; 9(4):. PubMed ID: 29206148
[TBL] [Abstract][Full Text] [Related]
3. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers.
Brandel C; Amharar Y; Rollinger JM; Griesser UJ; Cartigny Y; Petit S; Coquerel G
Mol Pharm; 2013 Oct; 10(10):3850-61. PubMed ID: 23984951
[TBL] [Abstract][Full Text] [Related]
4. Solubility and some crystallization properties of conglomerate forming chiral drug guaifenesin in water.
Fayzullin RR; Lorenz H; Bredikhina ZA; Bredikhin AA; Seidel-Morgenstern A
J Pharm Sci; 2014 Oct; 103(10):3176-82. PubMed ID: 25091705
[TBL] [Abstract][Full Text] [Related]
5. Application of preferential crystallization to resolve racemic compounds in a hybrid process.
Lorenz H; Polenske D; Seidel-Morgenstern A
Chirality; 2006 Nov; 18(10):828-40. PubMed ID: 16917833
[TBL] [Abstract][Full Text] [Related]
6. Enabling Direct Preferential Crystallization in a Stable Racemic Compound System.
Harfouche LC; Brandel C; Cartigny Y; Ter Horst JH; Coquerel G; Petit S
Mol Pharm; 2019 Nov; 16(11):4670-4676. PubMed ID: 31545612
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of preferential enrichment, an unusual enantiomeric resolution phenomenon caused by polymorphic transition during crystallization of mixed crystals composed of two enantiomers.
Tamura R; Fujimoto D; Lepp Z; Misaki K; Miura H; Takahashi H; Ushio T; Nakai T; Hirotsu K
J Am Chem Soc; 2002 Nov; 124(44):13139-53. PubMed ID: 12405843
[TBL] [Abstract][Full Text] [Related]
8. Physical-Chemical Properties of the Chiral Fungicide Fenamidone and Strategies for Enantioselective Crystallization.
Kort AK; Lorenz H; Seidel-Morgenstern A
Chirality; 2016 Jun; 28(6):514-20. PubMed ID: 27225331
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a solid solution of enantiomers in a racemate-forming system by seeding.
Huang J; Chen S; Guzei IA; Yu L
J Am Chem Soc; 2006 Sep; 128(36):11985-92. PubMed ID: 16953640
[TBL] [Abstract][Full Text] [Related]
10. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride.
Wang X; Wang XJ; Ching CB
Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072
[TBL] [Abstract][Full Text] [Related]
11. Potential of different techniques of preferential crystallization for enantioseparation of racemic compound forming systems.
Polenske D; Lorenz H; Seidel-Morgenstern A
Chirality; 2009 Aug; 21(8):728-37. PubMed ID: 18989897
[TBL] [Abstract][Full Text] [Related]
12. Chiral self assembled monolayers as resolving auxiliaries in the crystallization of valine.
Singh A; Myerson AS
J Pharm Sci; 2010 Sep; 99(9):3931-40. PubMed ID: 20533552
[TBL] [Abstract][Full Text] [Related]
13. Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state.
Duddu SP; Grant DJ
Pharm Res; 1992 Aug; 9(8):1083-91. PubMed ID: 1409382
[TBL] [Abstract][Full Text] [Related]
14. Predicting the relative solubilities of racemic and enantiopure crystals by density-functional theory.
Otero-de-la-Roza A; Cao BH; Price IK; Hein JE; Johnson ER
Angew Chem Int Ed Engl; 2014 Jul; 53(30):7879-82. PubMed ID: 24917528
[TBL] [Abstract][Full Text] [Related]
15. Application of direct crystallization for racemic compound propranolol hydrochloride.
Wang X; Lu J; Ching CB
J Pharm Sci; 2007 Oct; 96(10):2735-45. PubMed ID: 17549769
[TBL] [Abstract][Full Text] [Related]
16. The separation of racemic crystals into enantiomers by chiral block copolymers.
Mastai Y; Sedlák M; Cölfen H; Antonietti M
Chemistry; 2002 Jun; 8(11):2429-37. PubMed ID: 12180321
[TBL] [Abstract][Full Text] [Related]
17. Online monitoring of preferential crystallization of enantiomers.
Alvarez Rodrigo A; Lorenz H; Seidel-Morgenstern A
Chirality; 2004 Oct; 16(8):499-508. PubMed ID: 15290684
[TBL] [Abstract][Full Text] [Related]
18. Chiral symmetry breaking and complete chiral purity by thermodynamic-kinetic feedback near equilibrium: implications for the origin of biochirality.
Viedma C
Astrobiology; 2007 Apr; 7(2):312-9. PubMed ID: 17480162
[TBL] [Abstract][Full Text] [Related]
19. Symmetry, chirality and crystalline tendency: the polymorphism of triacylglycerols.
Craven RJ; Lencki RW
Food Funct; 2012 Mar; 3(3):228-33. PubMed ID: 22361723
[TBL] [Abstract][Full Text] [Related]
20. Disappearing Enantiomorphs: Single Handedness in Racemate Crystals.
Parschau M; Ernst KH
Angew Chem Int Ed Engl; 2015 Nov; 54(48):14422-6. PubMed ID: 26440779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
